Q2 2019 Vanda Pharmaceuticals Inc Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to Vanda Pharmaceuticals Second Quarter 2019 Earnings Conference Call.
(Operator Instructions)
I'd now like to introduce one of your hosts for today's conference, Jim Kelly, Executive Vice President and Chief Financial Officer. You may begin.
All right. Thank you, Tiffany. Good afternoon and thank you for joining us to discuss Vanda Pharmaceuticals' Second Quarter 2019 performance. Second quarter 2019 results were released this afternoon and are available on the SEC's EDGAR System and on our website, www.vandapharma.com. In addition, we are providing live and archived versions of this conference call on our website.
Joining me on today's call is Dr. Mihales Polymeropoulos, our President and CEO. Following my introductory remarks, Mihales will update you on our ongoing activities. I will then comment on our financial results before opening
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |